SBI Mutual Fund · Hybrid · Balanced Hybrid · Direct plan
SBI Balanced Hybrid Fund - Direct Plan - Growth
₹9.8177NAV on 31 Oct 2026Expense ratio 1.46%
4 Sept 2026NAV low 9.65 · high 10.04-1.9%
In plain words
Its worst fall from a peak in the last 3 years was -3.9%.
Past returns, not a promise of future returns or a recommendation.
Returns vs benchmark
| Period | Fund | Benchmark |
|---|---|---|
| 1 month | -1.4% | +1.9% |
Top holdings (30 Sept 2026)
Fund size ₹1,980 crore · 40 holdings · 41.8% in equity
| Company | Industry | Weight |
|---|---|---|
| Indian Overseas Bank | CARE A1+ | 7.58% |
| HDFC Bank Ltd. | CRISIL A1+ | 7.58% |
| Cholamandalam Investment & Finance Co. Ltd.Perpetual | [ICRA]AA | 6.19% |
| L&T Metro Rail (Hyderabad) Ltd. | CRISIL A1+ | 4.99% |
| Interise Trust | [ICRA]AAA | 4.55% |
| Bharti Telecom Ltd. | CRISIL AAA | 3.76% |
| TVS Credit Services Ltd. | CRISIL AA+ | 2.55% |
| Wheels India Ltd. | Auto Components | 1.88% |
| Sedemac Mechatronics Ltd. | Auto Components | 1.77% |
| Aequs Ltd. | Aerospace & Defense | 1.73% |
| HDFC Bank Ltd. | Banks | 1.72% |
| Kotak Mahindra Bank Ltd. | Banks | 1.69% |
| Sundaram Finance Ltd. | Finance | 1.65% |
| Innova Captab Ltd. | Pharmaceuticals & Biotechnology | 1.63% |
| Solar Industries India Ltd. | Chemicals & Petrochemicals | 1.59% |
Largest industries: CRISIL A1+ 12.6%, Auto Components 9.3%, Pharmaceuticals & Biotechnology 8.9%, CARE A1+ 7.6%, [ICRA]AA 6.2%, Finance 4.7%.
Other plan of this fund: SBI Balanced Hybrid Fund - Regular Plan - Growth